Dr. Catherine L. Laughlin, MD
Dermatology (Dermatology Physician)
- Medicare participating
At a glance
- Medical school
- University of Chicago, Pritzker School of Medicine (1993)
- Years since graduation
- 33
- In the NPI registry since
- 2006
- Medicare patients seen, 2024
- 760
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. NPIs were first issued in May 2005 and became required on claims in 2007–2008, so an early date usually means the clinician was already in practice before then. What an NPI is
Education and training
- 1993Medical school: University of Chicago, Pritzker School of Medicine
- 2006Registered with an NPI (national billing number; not a license date) — NPIs began in 2005, so practice likely started earlier
Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Dermatology Physician primary
MO license 112232
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- Cox Medical Centers Springfield, MO
Medical groups
- Dimmick Laughlin Dermatology LLC (6 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 760
- Services billed
- 3,525
- Patients’ average age
- 75
| Service | Times | Patients |
|---|---|---|
| Destruction of precancer skin growth, 2-14 growths | 1,287 | 271 |
| Established patient office or other outpatient visit, 20-29 minutes | 943 | 686 |
| Destruction of precancer skin growth, 1 growth | 542 | 396 |
| Biopsy of related skin growth, first growth | 251 | 213 |
| Destruction of skin growth, 1-14 growths | 104 | 91 |
| Established patient office or other outpatient visit, 30-39 minutes | 88 | 70 |
| Biopsy of related skin growth, each additional growth | 84 | 54 |
| Established patient office or other outpatient visit, 10-19 minutes | 67 | 61 |
| Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm | 39 | 29 |
| New patient office or other outpatient visit, 30-44 minutes | 36 | 36 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Clobetasol Propionate Other prescribers in Springfield, MO | 184 |
| Mometasone Furoate Other prescribers in Springfield, MO | 144 |
| Ciclopirox (ciclopirox olamine) | 132 |
| Betamethasone Dipropionate Other prescribers in Springfield, MO | 71 |
| Triamcinolone Acetonide Other prescribers in Springfield, MO | 67 |
| Doxycycline Hyclate Other prescribers in Springfield, MO | 61 |
| Fluticasone Propionate Other prescribers in Springfield, MO | 61 |
| Metronidazole Other prescribers in Springfield, MO | 55 |
| Fluorouracil Other prescribers in Springfield, MO | 46 |
| Valacyclovir (valacyclovir hcl) Other prescribers in Springfield, MO | 39 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 9 companies reported 57 payments worth $1,178 in total to this clinician.
| UCB, Inc. | $234 |
|---|---|
| Novartis Pharmaceuticals Corporation | $199 |
| Pfizer Inc. | $198 |
| Janssen Biotech, Inc. | $182 |
| AbbVie Inc. | $156 |
| Lilly USA, LLC | $85.12 |
| Leo Pharma Inc. | $47.11 |
| Amgen Inc. | $45.18 |
| Food and Beverage | $1,093 |
|---|---|
| Education | $84.99 |
What the payments were for
| Company | What it was for | Amount |
|---|---|---|
| Janssen Biotech, Inc. Apr 28, 2025 | Education TREMFYA · Immunology · in-kind | $84.99 |
Each payment as the company reported it, with the products it named. Meals are counted in the totals above but not listed one by one.
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.